LINDSTROM RICHARD L MD

SEC Form 4 insider trading activity

LINDSTROM RICHARD L MD has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including OCUL, LNSR, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.

On the most recent filing, LINDSTROM RICHARD L MD is listed as Director at OCULAR THERAPEUTIX, INC. Inside the rolling window, LINDSTROM RICHARD L MD reported 1 open-market purchase totaling $461K in OCUL and no open-market sales.

Companies traded

Other insiders at OCUL

Insider Buying

$461K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
OCUL
LINDSTROM RICHARD L MD
Purchase$461KFeb 24SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has LINDSTROM RICHARD L MD made?

LINDSTROM RICHARD L MD has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including OCUL, LNSR since 2026.

Which companies does LINDSTROM RICHARD L MD trade?

LINDSTROM RICHARD L MD has filed SEC Form 4 disclosures for 2 companies, including OCUL, LNSR.

When was LINDSTROM RICHARD L MD's most recent SEC Form 4 filing?

LINDSTROM RICHARD L MD's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.

What is LINDSTROM RICHARD L MD's total buy and sell value in the current window?

Inside the rolling retention window, LINDSTROM RICHARD L MD bought $461K and sold $0 based on SEC Form 4 filings.

What was LINDSTROM RICHARD L MD's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 60,229 OCUL shares on 2026-02-20, worth $461K, per SEC Form 4 filings.